Efficacy of chemoimmunotherapy with cyclophosphamide, interleukin-2 and lymphokine activated killer cells in an intraperitoneal murine tumour model

Keyphrases

• 2-dose 12%
• Antitumor Activity 12%
• Chemoimmunotherapy 100%
• Clinical Setting 12%
• Combination Treatment 25%
• Combined Treatment 12%
• Cyclophosphamide 100%
• Cyclophosphamide Treatment 12%
• Dose-limiting Toxicity 12%
• High-dose Cyclophosphamide 12%
• High-dose interleukin-2 12%
• Index Scoring 12%
• Inoculation 25%
• Interleukin-2 100%
• Intraperitoneal Tumor 25%
• Intravesical Immunotherapy 12%
• Lymphokine-activated Killer Cells 100%
• Moderate Dose 25%
• Murine Tumor Model 100%
• Peritoneal Cancer Index 12%
• Schedule-based 12%
• Scoring System 12%
• Second Dose 12%
• Single Modality 12%
• Survival Benefit 12%
• Synergize 12%
• Treatment Schedule 12%
• Treatment Strategy 12%
• Tumor 12%
• Tumor Cells 12%
• Tumor Growth 12%

Immunology and Microbiology

• Antineoplastic Activity 11%
• Cyclophosphamide 100%
• Drug Megadose 22%
• Immunotherapy 11%
• Interleukin 2 100%
• Lymphokine Activated Killer Cell 100%
• Mouse 11%
• Tumor Cell 11%

Veterinary Science and Veterinary Medicine

• Mouse 100%